Luspatercept for Clonal Cytopenias of Uncertain Significance

Abroad (travel likely)RecruitingPHASE2

Conditions

CCUS Clonal Cytopenia of Undetermined Significance · Anemia · Leukopenia · Thrombocytopenia · Neutropenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Weill Cornell Medical College, New York, New York, United States
Contact: Study coordinator (Pinkal Desai, MD) · pid9006@med.cornell.edu · 646-962-2700
Contact: Study coordinator (Ameenah Sukkur, BA) · ams4015@med.cornell.edu · 646-962-4580

Study leads

Pinkal Desai, MD
Principal Investigator
Weill Medical College of Cornell University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Preleukemia · Myelodysplastic Neoplasm · Cytopenia

Abroad (travel likely)RecruitingPHASE2

Copenhagen, Denmark

Early Intervention in High Risk CCUS

Clonal Cytopenia of Undetermined Significance · Cytopenia

Abroad (travel likely)RecruitingEARLY_PHASE1

Boston, United States

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Myeloid Malignancy · Inherited Bone Marrow Failure Syndrome · Clonal Expansion

Abroad (travel likely)Recruiting

Scottsdale, United States · Jacksonville, United States

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Myelodysplastic Syndromes · Chronic Myelomonocytic Leukemia · Clonal Cytopenia of Undetermined Significance

Abroad (travel likely)RecruitingPHASE2

Miami, United States · Houston, United States